Kenvue CEO Discusses Growth Outlook After J&J Unit Jumps 20% in Market Debut
Johnson & Johnson's consumer-health unit Kenvue made its debut on the New York Stock Exchange and jumped about 20% on Thursday. Thibaut Mongon, CEO of Kenvue, joined Cheddar News to discuss business growth goals and what lies ahead for its well-known pipeline of products, including Band-Aid, Neutrogena, Tylenol, among others.
Multiple activist investors have taken stakes in Salesforce, according to reports from several outlets, spurring speculation that the tech firm could soon face additional pressure to increase margins and trim payrolls.
Andrew Collins, the CEO of private aviation firm Sentient Jet, joined Cheddar News anchor Hena Doba on a Walk & Talk discussing the future of business and leisure travel.
Stocks closed higher on Wall Street as investors grow more convinced the Federal Reserve will keep downshifting the size of its rate hikes and as several major companies prepare to report their latest results.
The number of businesses that see a 50 percent chance or higher of a recession in 2022 has fallen from around two-thirds of respondents in October to just over half this month, according to survey.
